Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2- b ]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors.

MLA

Hartz, Richard A., et al. “Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2- b ]Pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors.” Journal of Medicinal Chemistry, vol. 66, no. 6, Mar. 2023, pp. 4231–52. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.3c00133.

APA

Hartz, R. A., Ahuja, V. T., Sivaprakasam, P., Xiao, H., Krause, C. M., Clarke, W. J., Kish, K., Lewis, H., Szapiel, N., Ravirala, R., Mutalik, S., Nakmode, D., Shah, D., Burton, C. R., Macor, J. E., & Dubowchik, G. M. (2023). Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2- b ]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors. Journal of Medicinal Chemistry, 66(6), 4231–4252. https://doi.org/10.1021/acs.jmedchem.3c00133

Chicago

Hartz, Richard A, Vijay T Ahuja, Prasanna Sivaprakasam, Hong Xiao, Carol M Krause, Wendy J Clarke, Kevin Kish, et al. 2023. “Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2- b ]Pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors.” Journal of Medicinal Chemistry 66 (6): 4231–52. doi:10.1021/acs.jmedchem.3c00133.